Cited by 434Ovarian function and disordersSexual Differentiation and DisordersHypothalamic control of reproductive hormones

Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood

Open access
Tata, Brooke, Mimouni, Nour El Houda, Barbotin, Anne-Laure, Malone, Samuel A., Loyens, Anne, Pigny, Pascal, Dewailly, Didier, Catteau-Jonard, Sophie +7 more·2018·Nature Medicine

Abstract

Polycystic ovary syndrome (PCOS) is the main cause of female infertility worldwide and corresponds with a high degree of comorbidities and economic burden. How PCOS is passed on from one generation to the next is not clear, but it may be a developmental condition. Most women with PCOS exhibit higher levels of circulating luteinizing hormone, suggestive of heightened gonadotropin-releasing hormone (GnRH) release, and anti-Müllerian hormone (AMH) as compared to healthy women. Excess AMH in utero may affect the development of the female fetus. However, as AMH levels drop during pregnancy in women with normal fertility, it was unclear whether their levels were also elevated in pregnant women with PCOS. Here we measured AMH in a cohort of pregnant women with PCOS and control pregnant women and found that AMH is significantly more elevated in the former group versus the latter. To determine whether the elevation of AMH during pregnancy in women with PCOS is a bystander effect or a driver of the condition in the offspring, we modeled our clinical findings by treating pregnant mice with AMH and followed the neuroendocrine phenotype of their female progeny postnatally. This treatment resulted in maternal neuroendocrine-driven testosterone excess and diminished placental metabolism of testosterone to estradiol, resulting in a masculinization of the exposed female fetus and a PCOS-like reproductive and neuroendocrine phenotype in adulthood. We found that the affected females had persistently hyperactivated GnRH neurons and that GnRH antagonist treatment in the adult female offspring restored their neuroendocrine phenotype to a normal state. These findings highlight a critical role for excess prenatal AMH exposure and subsequent aberrant GnRH receptor signaling in the neuroendocrine dysfunctions of PCOS, while offering a new potential therapeutic avenue to treat the condition during adulthood.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0035-5

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [68]Schaeffer M Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons Proceedings of the National Academy of Sciences of the United States of America 2013 110 1512 1517 23297228 PMC3557016
  2. [76]Moore AM Prescott M Marshall CJ Yip SH Campbell RE Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome Proceedings of the National Academy of Sciences of the United States of America 2015 112 596 601 25550522 PMC4299257

Cited by

Sorted by citations

Authors
Tata, B., Mimouni, N. E. H., Barbotin, A.-L., Malone, S. A., Loyens, A., Pigny, P., Dewailly, D., Catteau-Jonard, S., Sundström-Poromaa, I., Piltonen, T. T., Dal Bello, F., Medana, C., Prevot, V., Clasadonte, J., & Giacobini, P.
Affiliations
  • Inserm (FR)
  • Université de Lille (FR)
  • Oulu University Hospital (FI)
  • University of Turin (IT)
Corresponding author
Giacobini, Paolo
Venue
Nature Medicine
Published
2018-05-14
Volume
24
Issue
6
Pages
834-846
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2803052640
Cited by
434
References
76
Citations by year
2026: 33 · 2025: 49 · 2024: 53 · 2023: 53 · 2022: 65 · 2021: 57 · 2020: 59 · 2019: 47 · 2018: 18
FWCI
48.35
Type
journal article
Language
en
Open access
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
  • HAL (submittedVersion)
Funders
Agence Nationale de la Recherche (ANR-14-CE12-0015)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
polycystic ovary syndrome, anti-Müllerian hormone, prenatal hormone exposure, fetal programming, GnRH neurons, neuroendocrine dysfunction, female infertility, mouse model
MeSH terms
Adult, Animals, Brain, Female, Fertility, Fetus, Humans, Luteinizing Hormone, Gonadotropin-Releasing Hormone, Mice, Inbred C57BL, Neurons, Neurosecretory Systems, Ovary, Phenotype, Placenta, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Trimester, Second, Case-Control Studies, Estrous Cycle, Green Fluorescent Proteins, Anti-Mullerian Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review